The role of product lines in determining the degree and speed of integration: evidence from the pharmaceutical MNCs in cross-border acquisitions
by Robina Rashid; Yuosre F. Badir; Adeel Tariq; Bilal Afsar
European J. of International Management (EJIM), Vol. 17, No. 1, 2022

Abstract: Despite the growing number of acquisitions of Business Units (BUs) by Multinational Companies (MNCs), international business literature is limited to investigating the post-acquisition integration at the firm level. Therefore, this research investigates MNCs' strategic motivation in acquiring BUs and how they manage the post-acquisition integration at the BU level. Specifically, this article focuses on studying the pivotal role of acquired BU's product lines in determining the degree and speed of integration. Using multiple case study method in cross-border acquisitions, the analysis reveals three findings. First, acquired BU's product lines are the strategic motive for the acquirer MNCs and, therefore, become significant in the decisions taken during post-acquisition integration. Second, the three phases of acquired product lines, namely marketed, upcoming, and Research and Development (R&D) pipeline, set the speed of integration from fast to slow. Third, acquired product lines' market relatedness determines the degree of integration between the acquirer and acquired BUs.

Online publication date: Mon, 20-Dec-2021

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the European J. of International Management (EJIM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com